NCT00357734 - Iressa Follow-up Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Lung CancerBreast Cancer

Interventions

DRUG

Gefitinib

ZD1839 at a daily dose of 250 mg or 500 mg depending on final dose in parent trial

Trial Locations (7)

Research Site, Freiburg im Breisgau

Research Site, Gauting

Research Site, Großhansdorf

Research Site, Hemer

Research Site, Jena

Research Site, Minden

Research Site, Tübingen